Through the Lens: How Video Is Reshaping Content

The growth and opportunity of video production have fundamentally changed the concept of content. It’s a powerful marketing tool for business. Consumers spend, on average, six hours and 48 minutes a week watching online video. It’s a new frontier for business storytelling, and it works, with 93% of marketers that use it saying they gained new customers. A career videographer Jesper Sohof shared his thoughts on the evolution of business video and how he maintains a healthy career as a freelancer in Europe.

Sohof was interested in cameras at an early age; “I was the one in school with a camera filming everyone.” He then went on to study business but soon learned he wanted to be on the creative side of things.

He started his own production company and has been working as a freelancer for years throughout Europe. He has home bases in Denmark and Spain. “I’ve worked all over Europe with different people from different cultures. It’s been wonderful. I speak Danish, of course, and German, French, Spanish, and other Scandinavian languages. It’s a necessity being from Denmark,” he said.

Much has changed in the past few years in terms of equipment. “Everything’s smaller, lighter, much easier to be mobile and on the go. The quality improved, too,” Sohof commented.

Sohof focuses a lot on corporate videos while also doing news segments. The pandemic slowed business at first, but since then, he’s had more work than most since foreign journalists can’t travel. He’s picked up more business on the news side and live streaming. “I’ve been doing seminars that can’t take place online, so now groups are live streaming to give audiences access,” he added.

He’s very passionate about helping brands tell their stories through video—mixing entertainment with education. “The camera gives storytelling a new perspective. I really enjoy finding new ways to tell corporate stories. The recent shoot I did with Marketscale for Microdrones was very exciting and a great way to entertain and educate on the product,” Sohof commented.

Follow In Focus Every Other Friday!

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More